Walleye Trading’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Walleye Trading’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-21,936	Closed	-$51K	–	5879
2022 Q1	$51K	Sell	21,936 -76,083	-78%	-$237K	﹤0.01%	4508
2021 Q4	$456K	Sell	98,019 -30,346	-24%	-$188K	﹤0.01%	3056
2021 Q3	$979K	Buy	+128,365	New	+$1.09M	﹤0.01%	2226
2017 Q2	–	Sell	-11,800	Closed	-$47K	–	5091
2017 Q1	$47K	Buy	+11,800	New	+$59.2K	﹤0.01%	3809
2016 Q1	–	Sell	-6,100	Closed	-$53K	–	5975
2015 Q4	$53K	Buy	+6,100	New	+$51.5K	﹤0.01%	3808
2015 Q3	–	Sell	-700	Closed	-$12K	–	5653
2015 Q2	$12K	Buy	+700	New	+$8.99K	﹤0.01%	4237

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Walleye Trading's SRNE Position: Q2 2022 in Review

Walleye Trading sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2022, closing a stake of 21,936 shares — an estimated $51K sold.

Walleye Trading first reported a position in SRNE in Q2 2015 and held it in 6 quarters. The position peaked at $979K in Q3 2021. 229 funds tracked by Wall St. Rank hold SRNE as of Q2 2022.

Walleye Trading reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2022 after selling out during the quarter.
Walleye Trading sold 21,936 Sorrento Therapeutics, Inc. shares in Q2 2022, an estimated $51K.
Walleye Trading first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 6 quarters.
Walleye Trading's Sorrento Therapeutics, Inc. position peaked at $979K in Q3 2021.
229 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.